Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSEPU.L Regulatory News (SEPU)

  • There is currently no data for SEPU

New York City Transit contract

15 Jul 2016 07:00

RNS Number : 2662E
Sepura PLC
15 July 2016
 

RNS Reach

15 July 2016

 

Sepura plc

 

New York City Transit contract

 

Sepura plc (LSE: SEPU, 'the Group', or 'Sepura'), a leading global provider of critical communications solutions, has now been formally contracted to supply a TETRA network for New York City Transit. The Group stated on 4 April 2016 that it had received a "Notice to Proceed" pending the signing of the full contract by its partner.

 

The contract, valued at c. $34 million, covers system design, project management and the supply of 40 base stations together with a Teltronic CeCoCo Command and Control solution and approximately 7,500 terminals.

 

Gordon Watling, Chief Executive Officer, commented

 

"This contract endorses both our acquisition of Teltronic and our strategy to focus on both the global transport sector and developing our business in North America - the two fastest growing segments for TETRA."

 

Further information

 

Sepura

+44 1223 876000

Gordon Watling, Chief Executive Officer

Richard Smith, Chief Financial Officer

Peter Connor, Investor Relations

Instinctif Partners

+44 20 7457 2020

Adrian Duffield / Kay Larsen/ Chantal Woolcock

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRARIMTTMBTBTPF
Date   Source Headline
24th May 20176:22 pmRNSCash cancellation of entitlements
24th May 201712:40 pmRNSScheme of arrangement becomes effective
24th May 20179:31 amRNSHolding(s) in Company
23rd May 20174:52 pmRNSTransfer of Treasury Shares & Allotment of Shares
22nd May 20172:50 pmRNSCourt sanction of scheme of arrangement
22nd May 20179:13 amRNSForm 8.5 (EPT/RI)
16th May 20177:00 amRNSAnticipated Closing Timetable
15th May 20178:53 amRNSForm 8.5 (EPT/RI)
12th May 20176:12 pmRNSRegulatory Update
11th May 20174:40 pmRNSSecond Price Monitoring Extn
11th May 20174:35 pmRNSPrice Monitoring Extension
9th May 20177:00 amRNSFurther update on regulatory reviews
8th May 20171:49 pmRNSForm 8.3 - [Sepura Plc]
8th May 20171:09 pmRNSForm 8.3 - [Sepura Plc]
5th May 20172:25 pmRNSForm 8.3 - [Sepura Plc]
5th May 20177:00 amRNSGerman Government proposed public interest review
3rd May 20172:01 pmRNSForm 8.3 - [Sepura Plc]
25th Apr 20177:00 amRNSUpdate on Spanish Competition Approvals
21st Apr 20173:01 pmRNSForm 8.3 - [Sepura Plc]
20th Apr 20172:18 pmRNSForm 8.3 - [Sepura Plc]
19th Apr 20173:36 pmRNSForm 8.3 - [Sepura Plc]
13th Apr 20172:41 pmRNSForm 8.3 - Sepura plc
12th Apr 20172:48 pmRNSForm 8.3 - [Sepura Plc]
12th Apr 20172:30 pmRNSForm 8.3 - Sepura plc
11th Apr 20172:28 pmRNSForm 8.3 - [Sepura Plc]
11th Apr 20179:53 amRNSForm 8.3 - [Sepura Plc]
11th Apr 20177:00 amRNSUK Government public interest review
5th Apr 20179:35 amRNSForm 8.5 (EPT/RI)
4th Apr 20173:58 pmRNSHolding(s) in Company
4th Apr 20171:35 pmRNSForm 8.3 - Sepura Ltd
4th Apr 201710:12 amRNSForm 8.5 (EPT/RI)
4th Apr 20178:08 amRNSHolding(s) in Company
3rd Apr 20171:29 pmRNSForm 8.3 - [Sepura Plc]
3rd Apr 201712:30 pmRNSOffer Update
3rd Apr 201710:08 amRNSForm 8.5 (EPT/RI)
31st Mar 20177:00 amRNSDiscussions with lenders
30th Mar 20172:59 pmRNSForm 8.3 - [Sepura Plc]
29th Mar 20177:00 amRNSCompetition approvals
27th Mar 20177:00 amRNSUpdate on German and Spanish Competition Approvals
20th Mar 20171:44 pmRNSForm 8.3 - [Sepura Plc]
7th Mar 20174:35 pmRNSPrice Monitoring Extension
22nd Feb 20172:50 pmRNSForm 8.3 - [Sepura Plc]
21st Feb 20172:05 pmRNSForm 8.3 - [Sepura Plc]
16th Feb 20173:10 pmRNSForm 8.3 - Sepura plc
16th Feb 20172:20 pmRNSForm 8.3 - [Sepura Plc]
14th Feb 20172:14 pmRNSForm 8.3 - [Sepura Plc]
14th Feb 20179:40 amRNSForm 8 (DD) - Sepura plc
14th Feb 20178:05 amRNSForm 8.5 (EPT/RI)
13th Feb 20177:00 amRNSUpdate on German and Spanish Competition Approvals
10th Feb 20172:08 pmRNSForm 8.3 - [Sepura Plc]

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.